Literature DB >> 16256231

Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.

Roel J H M Steenbakkers1, Joop C Duppen, Isabelle Fitton, Kirsten E I Deurloo, Lambert Zijp, Apollonia L J Uitterhoeve, Patrick T R Rodrigus, Gijsbert W P Kramer, Johan Bussink, Katrien De Jaeger, José S A Belderbos, Augustinus A M Hart, Peter J C M Nowak, Marcel van Herk, Coen R N Rasch.   

Abstract

BACKGROUND AND
PURPOSE: To evaluate the process of target volume delineation in lung cancer for optimization of imaging, delineation protocol and delineation software. PATIENTS AND METHODS: Eleven radiation oncologists (observers) from five different institutions delineated the Gross Tumor Volume (GTV) including positive lymph nodes of 22 lung cancer patients (stages I-IIIB) on CT only. All radiation oncologist-computer interactions were recorded with a tool called 'Big Brother'. For each radiation oncologist and patient the following issues were analyzed: delineation time, number of delineated points and corrections, zoom levels, level and window (L/W) settings, CT slice changes, use of side windows (coronal and sagittal) and software button use.
RESULTS: The mean delineation time per GTV was 16 min (SD 10 min). The mean delineation time for lymph node positive patients was on average 3 min larger (P = 0.02) than for lymph node negative patients. Many corrections (55%) were due to L/W change (e.g. delineating in mediastinum L/W and then correcting in lung L/W). For the lymph node region, a relatively large number of corrections was found (3.7 corr/cm2), indicating that it was difficult to delineate lymph nodes. For the tumor-atelectasis region, a relative small number of corrections was found (1.0 corr/cm2), indicating that including or excluding atelectasis into the GTV was a clinical decision. Inappropriate use of L/W settings was frequently found (e.g. 46% of all delineated points in the tumor-lung region were delineated in mediastinum L/W settings). Despite a large observer variation in cranial and caudal direction of 0.72 cm (1 SD), the coronal and sagittal side windows were not used in 45 and 60% of the cases, respectively. For the more difficult cases, observer variation was smaller when the coronal and sagittal side windows were used.
CONCLUSIONS: With the 'Big Brother' tool a method was developed to trace the delineation process. The differences between observers concerning the delineation style were large. This study led to recommendations on how to improve delineation accuracy by adapting the delineation protocol (guidelines for L/W use) and delineation software (double window with lung and mediastinum L/W settings at the same time, enforced use of coronal and sagittal views) and including FDG-PET information (lymph nodes and atelectasis).

Entities:  

Mesh:

Year:  2005        PMID: 16256231     DOI: 10.1016/j.radonc.2005.09.017

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  41 in total

1.  Human-computer interaction in radiotherapy target volume delineation: a prospective, multi-institutional comparison of user input devices.

Authors: 
Journal:  J Digit Imaging       Date:  2011-10       Impact factor: 4.056

Review 2.  Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities.

Authors:  Wouter van Elmpt; Catharina M L Zegers; Marco Das; Dirk De Ruysscher
Journal:  J Thorac Dis       Date:  2014-04       Impact factor: 2.895

3.  Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.

Authors:  Jayashree Kalpathy-Cramer; Musaddiq Awan; Steven Bedrick; Coen R N Rasch; David I Rosenthal; Clifton D Fuller
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

4.  PET-CT in the staging and treatment of non-small-cell lung cancer.

Authors:  Patricia Ibeas; Blanca Cantos; José Manuel Gasent; Begoña Rodríguez; Mariano Provencio
Journal:  Clin Transl Oncol       Date:  2011-06       Impact factor: 3.405

5.  Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Evaluation Platform for Radiotherapy Target Delineation.

Authors:  Jayashree Kalpathy-Cramer; Clifton David Fuller
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

6.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

7.  The tumor shape changes of nasopharyngeal cancer during chemoradiotherapy: the estimated margin to cover the geometrical variation.

Authors:  Wenyong Tan; Jianzeng Ye; Ruilian Xu; Xianming Li; Wan He; Xiaohong Wang; Yanping Li; Desheng Hu
Journal:  Quant Imaging Med Surg       Date:  2016-04

8.  Decreased 3D observer variation with matched CT-MRI, for target delineation in Nasopharynx cancer.

Authors:  Coen R N Rasch; Roel J H M Steenbakkers; Isabelle Fitton; Joop C Duppen; Peter J C M Nowak; Frank A Pameijer; Avraham Eisbruch; Johannes H A M Kaanders; Frank Paulsen; Marcel van Herk
Journal:  Radiat Oncol       Date:  2010-03-15       Impact factor: 3.481

9.  Partial volume correction strategies for quantitative FDG PET in oncology.

Authors:  Nikie J Hoetjes; Floris H P van Velden; Otto S Hoekstra; Corneline J Hoekstra; Nanda C Krak; Adriaan A Lammertsma; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-27       Impact factor: 9.236

10.  A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen.

Authors:  Emmanuel Rios Velazquez; Hugo J W L Aerts; Yuhua Gu; Dmitry B Goldgof; Dirk De Ruysscher; Andre Dekker; René Korn; Robert J Gillies; Philippe Lambin
Journal:  Radiother Oncol       Date:  2012-11-15       Impact factor: 6.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.